Larvol Delta - CERo-Therapeutics-to-Present-LateBreaking-Oral-Poster-Session-Highlighting-Interim-Phase-1-Data-from-CERTAINT-Trial-Highlighting-Platelet-Transfusion-Independence-in-a-HighRisk-MDSAML-Patient

CER-1236 - CERo Therap

https://www.globenewswire.com/news-release/2026/02/04/3232151/0/en/cero-therapeutics-to-present-late-breaking-oral-poster-session-highlighting-interim-phase-1-data-from-certain-t-trial-highlighting-platelet-transfusion-independence-in-a-high-risk-.html

Feb 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next